Tech Company Financing Transactions
American Injectables Funding Round
American Injectables, based in Brooksville, secured $19 million from New Rhein Healthcare Investors and private investors.
Transaction Overview
Company Name
Announced On
8/29/2022
Transaction Type
Venture Equity
Amount
$19,000,000
Round
Series A
Investors
New Rhein Healthcare Investors (Lead Investor)
Proceeds Purpose
Series A enables the Company to scale manufacturing capabilities, fund R&D and launch its first product.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
15261 Telcom Dr.
Brooksville, FL 34604
USA
Brooksville, FL 34604
USA
Phone
Undisclosed
Website
Email Address
Overview
American Injectables is a US-based manufacturer of sterile injectable parenteral drugs with a world-class facility focused on ready-to-use pre-filled syringes and vials. The company's product line includes small molecule 505(b)2 and 505(j) ready-to-use syringe and vial products, and it serves as an out-sourced contract manufacturing partner for strategic pharmaceutical companies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Adam Levitt
Chief Financial Officer
Gilad Shadur
Chief Operating Officer
Ben Boling
VP - Operations
Travis Allen
VP - Regulatory Affairs
Alison Brown
Browse more venture capital transactions:
Prev: 8/29/2022: Opkey venture capital transaction
Next: 8/29/2022: Ox Security venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. All VC database entries reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs